CAMP4 THERAPEUTICS CORP
CAMPNASDAQ🏆 #3497 by market capEarnings Nov 4US Equity
——
Quote unavailableTrack CAMP
Get earnings, price moves & breaking news on Telegram
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$229M
Small Cap
📈Revenue Growth (YoY)
436.5%
High Growth
📊Gross Margin
77.8%
High
💵FCF Margin
-681.2%
Thin
⚖️P/S Ratio
54.3x
Expensive
Otter Score
64
Fair
No chart data available for CAMP.
Trading Snapshot
- Day Range
- —
- 52-Week Range
- $2.90 – $7.75
- Volume (shares)
- —
- Avg Volume (shares)
- —
- Shares Outstanding
- 62.8M
- Next Earnings
- 2026-11-04
Fundamentals Snapshot
- Annual Revenue
- $3M
- Last Q Revenue
- $2M
- P/E Ratio
- -1.6
- P/S Ratio
- 54.3x
- EPS (TTM)
- $-1.85
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +166.1%
CAMP4 THERAPEUTICS CORP
CAMPFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$3M▲ +436.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
53.1%▼ −46.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$52M▼ −1.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$30M▼ −35.2% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
51.9M▲ +166.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$108M▲ +$52M YoY
StockOtter · stockotter.spaceAbout CAMP4 THERAPEUTICS CORP
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
64/100
Analyst data unavailable.
Latest News & Updates
News unavailable.